ARCHIVES

Iniparib Doesn’t Meet Survival, PFS Endpoints In Phase III Trial in Triple-Negative Breast Cancer

This article is from The Cancer Letter archive.

Vol. 34 No. 2 | February 25, 2011

Download PDF Visit The Full Archive

Related Articles

NIH closes Meeting of BSC Chairmen, Violation of Open Meetings Law Alleged

August 5, 1994

Trials Approved In October

December 28, 2001

Annual Report Finds Decreases In Overall Cancer Rates

December 11, 2009

New Grant Concepts Totaling $3 million a Year Approved, With New Contract, Two Recompetitions

July 10, 1987

NSABP Protests NIH Rejection Of P-4 Appeal.

May 2, 2008

Science Policy: Increased Cancer Death Rate For Atomic Vets Not Significant, OIM Says

October 29, 1999